f-Met-Leu-Phe stimulates nitric oxide production in chick embryo neurons: the role of NF-kB

References

• Marasco, W.A.; Phan, S.H.; Krutzsch, H.; Showell, H.J.; Feltner, D.E.; Nairn, R.; Becker, E.L.; Ward, P.A. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 1984; 259 (9):5430–5439.
   PubMedGoogle Scholar
• Boulay, F.; Tardif, M.; Brouchon, L.; Vignais, P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 1990; 29 (50):11123–11133.
   Google Scholar
• Ali, H.; Haribabu, B.; Richardson, R.M.; Snyderman, R. Mechanisms of inflammation and leukocyte activation. Med.Clin. North Am. 1997; 81 (1):1–28.
   PubMedGoogle Scholar
• Haviland, D.L.; Borel, A.C.; Fleischer, D.T.; Haviland, J.C.; Wetsel, R.A. Structure, 5’-flanking sequence, and chromosome location of the human N-formyl peptide receptor gene. A single-copy gene comprised of two exons on chromosome 19q.13.3 that yields two distinct transcripts by alternative polyadenylation. Biochemistry 1993; 32 (16):4168–4174.
   PubMedGoogle Scholar
• Bockaert, J.; Pin, J.P. Molecular tinkering of G protein-coupled receptors: An evolutionary success. EMBO J. 1999; 18 (7):1723–1729.
   PubMed Web of Science ®Google Scholar
• Gudermann, T.; Kalkbrenner, F.; Dippel, E.; Laugwitz, K.L.; Schultz, G. Specificity and complexity of receptor-G-protein interaction. Adv. Second Messenger Phosphoprotein Res. 1997; 31:253–262.
   PubMedGoogle Scholar
• Ye, R.D.; Quehenberger, O.; Thomas, K.M.; Navarro, J.; Cavanagh, S.L.; Prossnitz, E.R.; Cochrane, C.G. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications. J. Immunol. 1993; 150 (4):1383–1394.
   PubMedGoogle Scholar
• Gao, J.L.; Murphy, P.M. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 1993; 268 (34): 25395–25401.
   PubMedGoogle Scholar
• Alvarez, V.; Coto, E.; Setién, F.; González-Roces, S.; López-Larrea, C. Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates. Immunogenetics 1996; 44 (6):446–452.
   PubMedGoogle Scholar
• Lacy, M.; Jones, J.; Whittemore, S.R.; Haviland, D.L.; Wetsel, R.A.; Barnum, S.R. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J.Neuroimmunol. 1995; 61 (1):71–78.
   PubMedGoogle Scholar
• McCoy, R.; Haviland, D.L.; Molmenti, E.P.; Ziambaras, T.; Wetsel, R.A.; Perlmutter, D.H. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 1995; 182 (1):207–217.
   PubMedGoogle Scholar
• Becker, E.L.; Forouhar, F.A.; Grunnet, M.L.; Boulay, F.; Tardif, M.; Bormann, B.J.; Sodja, D.; Ye, R.D.; Woska, J.R. Jr.; Murphy, P.M. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res. 1998; 292 (1):129–135.
   PubMedGoogle Scholar
• Panaro, M.A.; Mitolo, V. Cellular responses to FMLP challenging: A mini-review. Immunopharmacol. Immunotoxicol. 1999; 21 (3):397–419.
   PubMedGoogle Scholar
• Le, Y.; Oppenheim, J.J.; Wang, J.M. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 2001; 12 (1):91–105.
   PubMedGoogle Scholar
• Le, Y.; Murphy, P.M.; Wang, J.M. Formyl-peptide receptors revisited. Trends Immunol. 2002; 23 (11):541–548.
   PubMedGoogle Scholar
• Panaro, M.A.; Acquafredda, A.; Sisto, M.; Lisi, S.; Maffione, A.B.; Mitolo, V. Biological role of the N-formyl peptide receptors. Immunopharmacol. Immunotoxicol. 2006; 28 (1):103–127.
   PubMedGoogle Scholar
• Panaro, M.A.; Cianciulli, A.; Lisi, S.; Sisto, M.; Acquafredda, A.; Mitolo, V. Formyl peptide receptor expression in birds. Immunopharmacol. Immunotoxicol. 2007; 29 (1):1–16.
   PubMedGoogle Scholar
• Ding, A.H.; Nathan, C.F.; Stuehr, D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 1988; 141 (7):2407–2412.
   PubMedGoogle Scholar
• Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72:248–254.
   PubMed Web of Science ®Google Scholar
• Vila-del Sol, V.; Díaz-Muñoz, M.D.; Fresno, M. Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages. J. Leukoc. Biol. 2007; 81 (1):272–283.
   PubMedGoogle Scholar
• Saluk-Juszczak, J.; Wachowicz, B. The proinflammatory activity of lipopolysaccharide. Postepy. Biochem. 2005; 51 (3):280–287.
   PubMedGoogle Scholar
• Knowles, H.J.; Harris, A.L. Macrophages and the hypoxic tumour microenvironment. Front Biosci. 2007; 12:4298–4314.
   PubMed Web of Science ®Google Scholar
• Panaro, M.A.; Brandonisio, O.; Acquafredda, A.; Sisto, M.; Mitolo, V. Evidences for iNOS expression and nitric oxide production in the human macrophages. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2003; 3 (3):210–221.
   PubMedGoogle Scholar
• Poluha, W.; Schonhoff, C.M.; Harrington, K.S.; Lachyankar, M.B.; Crosbie, N.E.; Bulseco, D.A.; Ross, A.H. A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells. J. Biol. Chem. 1997; 272 (38):24002–24007.
   PubMedGoogle Scholar
• Muñoz-Fernández, M.A.; Fresno, M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 1998; 56 (3):307–340.
   PubMedGoogle Scholar
• Jaken, S. Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 1996; 8 (2):168–173.
   PubMedGoogle Scholar
• Dekker, L.V.; Leitges, M.; Altschuler, G.; Mistry, N.; McDermott, A.; Roes, J.; Segal, AW. Protein kinase C-beta contributes to NADPH oxidase activation in neutrophils. Biochem. J. 2000; 347:285–289.
   PubMed Web of Science ®Google Scholar
• Spisani, S.; Falzarano, S.; Traniello, S.; Nalli, M.; Selvatici, R. A ‘pure’ chemoattractant formylpeptide analogue triggers a specific signaling pathway in human neutrophil chemotaxis. FEBS J. 2005; 272 (4):883–891.
   PubMedGoogle Scholar
• Selvatici, R.; Falzarano, S.; Mollica, A.; Spisani, S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur. J. Pharmacol. 2006; 534 (1–3):1–11.
   PubMedGoogle Scholar
• Pizzi, M.; Spano, P. Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms. Eur. J. Pharmacol. 2006; 545 (1):22–28.
   PubMedGoogle Scholar
• Rao, K.M. Molecular mechanisms regulating iNOS expression in various cell types. J. Toxicol. Environ. Health B. Crit. Rev. 2000; 3 (1): 27–58.
   PubMedGoogle Scholar
• Browning, D.D.; Pan, Z.K.; Prossnitz, E.R.; Ye, R.D. Cell type- and developmental stage-specific activation of NF-kappaB by fMet-Leu-Phe in myeloid cells. J. Biol. Chem. 1997; 272 (12): 7995–8001.
   PubMedGoogle Scholar
• Heneka, M.T.; Feinstein, D.L. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 2001; 114 (1–2):8–18.
   PubMedGoogle Scholar
• Mémet, S. NF-kappaB functions in the nervous system: From development to disease. Biochem. Pharmacol. 2006; 72 (9): 1180–1195.
   PubMedGoogle Scholar
• Kleinert, H.; Schwarz, P.M.; Förstermann, U. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 2003; 384 (10–11):1343–1364.
   PubMedGoogle Scholar
• Kaltschmidt, B.; Widera, D.; Kaltschmidt, C. Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta. 2005; 1745 (3):287–299.
   PubMed Web of Science ®Google Scholar
• Tomita, N.; Morishita, R.; Tomita, S.; Yamamoto, K.; Aoki, M.; Matsushita, H.; Hayashi, S.; Higaki, J.; Ogihara, T. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells. J. Hypertens. 1998; 16:993–1000.
   PubMed Web of Science ®Google Scholar
• Camandola, S.; Mattson, M.P. Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression. J. Neurosci. Res. 2000; 61 (2):134–139.
   PubMedGoogle Scholar
• Shou, Y.; Li, N.; Li, L.; Borowitz, J.L.; Isom, G.E. NF-kappaB-mediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis. J. Neurochem. 2002; 81 (4):842–852.
   PubMed Web of Science ®Google Scholar
• Mattson, M.P. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 2005; 30 (6–7):883–893.
   PubMed Web of Science ®Google Scholar
• Mattson, M.P.; Culmsee, C.; Yu, Z.; Camandola, S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 2000; 74 (2):443–456.
   PubMedGoogle Scholar